RIPK1 and non-small cell lung carcinoma: By contrast, our study revealed that aberrant expression of RIPK1 alone could influence the proliferation, migration, and apoptosis of NSCLC cell lines (Figure 5, Figure 6 and Figure 7), which might indicate different regulatory mechanisms of RIPK1 in different cells.